These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1864 related articles for article (PubMed ID: 16202350)

  • 1. A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study.
    Hobbs FD; Fitzmaurice DA; Mant J; Murray E; Jowett S; Bryan S; Raftery J; Davies M; Lip G
    Health Technol Assess; 2005 Oct; 9(40):iii-iv, ix-x, 1-74. PubMed ID: 16202350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomised controlled trial and cost effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in the over 65s: (SAFE) [ISRCTN19633732].
    Swancutt D; Hobbs R; Fitzmaurice D; Mant J; Murray E; Jowett S; Raftery J; Bryan S; Davies M; Lip G
    BMC Cardiovasc Disord; 2004 Jul; 4():12. PubMed ID: 15283871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of systematic screening for the detection of atrial fibrillation.
    Moran PS; Flattery MJ; Teljeur C; Ryan M; Smith SM
    Cochrane Database Syst Rev; 2013 Apr; (4):CD009586. PubMed ID: 23633374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening strategies for atrial fibrillation: a systematic review and cost-effectiveness analysis.
    Welton NJ; McAleenan A; Thom HH; Davies P; Hollingworth W; Higgins JP; Okoli G; Sterne JA; Feder G; Eaton D; Hingorani A; Fawsitt C; Lobban T; Bryden P; Richards A; Sofat R
    Health Technol Assess; 2017 May; 21(29):1-236. PubMed ID: 28629510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for atrial fibrillation in patients aged 65 years or over attending annual flu vaccination clinics at a single general practice.
    Rhys GC; Azhar MF; Foster A
    Qual Prim Care; 2013; 21(2):131-40. PubMed ID: 23735694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic screening for the detection of atrial fibrillation.
    Moran PS; Teljeur C; Ryan M; Smith SM
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD009586. PubMed ID: 27258214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lead-I ECG for detecting atrial fibrillation in patients with an irregular pulse using single time point testing: a systematic review and economic evaluation.
    Duarte R; Stainthorpe A; Greenhalgh J; Richardson M; Nevitt S; Mahon J; Kotas E; Boland A; Thom H; Marshall T; Hall M; Takwoingi Y
    Health Technol Assess; 2020 Jan; 24(3):1-164. PubMed ID: 31933471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of screening for atrial fibrillation in primary care with a handheld, single-lead electrocardiogram device in the Netherlands.
    Jacobs MS; Kaasenbrood F; Postma MJ; van Hulst M; Tieleman RG
    Europace; 2018 Jan; 20(1):12-18. PubMed ID: 27733465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial Fibrillation Screen, Management, and Guideline-Recommended Therapy in the Rural Primary Care Setting: A Cross-Sectional Study and Cost-Effectiveness Analysis of eHealth Tools to Support All Stages of Screening.
    Orchard J; Li J; Freedman B; Webster R; Salkeld G; Hespe C; Gallagher R; Patel A; Kamel B; Neubeck L; Lowres N
    J Am Heart Assoc; 2020 Sep; 9(18):e017080. PubMed ID: 32865129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opportunistic screening versus usual care for diagnosing atrial fibrillation in general practice: a cluster randomised controlled trial.
    Kaasenbrood F; Hollander M; de Bruijn SH; Dolmans CP; Tieleman RG; Hoes AW; Rutten FH
    Br J Gen Pract; 2020 Jun; 70(695):e427-e433. PubMed ID: 31988084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.
    Shepherd J; Jones J; Frampton GK; Tanajewski L; Turner D; Price A
    Health Technol Assess; 2008 Jun; 12(28):iii-iv, ix-95. PubMed ID: 18547499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial.
    Fitzmaurice DA; Hobbs FD; Jowett S; Mant J; Murray ET; Holder R; Raftery JP; Bryan S; Davies M; Lip GY; Allan TF
    BMJ; 2007 Aug; 335(7616):383. PubMed ID: 17673732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review and cost-effectiveness evaluation of 'pill-in-the-pocket' strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy.
    Saborido CM; Hockenhull J; Bagust A; Boland A; Dickson R; Todd D
    Health Technol Assess; 2010 Jun; 14(31):iii-iv, 1-75. PubMed ID: 20569652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study.
    Lowres N; Neubeck L; Salkeld G; Krass I; McLachlan AJ; Redfern J; Bennett AA; Briffa T; Bauman A; Martinez C; Wallenhorst C; Lau JK; Brieger DB; Sy RW; Freedman SB
    Thromb Haemost; 2014 Jun; 111(6):1167-76. PubMed ID: 24687081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of a community-based screening programme for chronic atrial fibrillation in Japan.
    Maeda K; Shimbo T; Fukui T
    J Med Screen; 2004; 11(2):97-102. PubMed ID: 15153326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation.
    Rodgers M; McKenna C; Palmer S; Chambers D; Van Hout S; Golder S; Pepper C; Todd D; Woolacott N
    Health Technol Assess; 2008 Nov; 12(34):iii-iv, xi-xiii, 1-198. PubMed ID: 19036232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of targeted screening for the identification of patients with atrial fibrillation: evaluation of a machine learning risk prediction algorithm.
    Hill NR; Sandler B; Mokgokong R; Lister S; Ward T; Boyce R; Farooqui U; Gordon J
    J Med Econ; 2020 Apr; 23(4):386-393. PubMed ID: 31855091
    [No Abstract]   [Full Text] [Related]  

  • 18. Acceptability, benefit and costs of early screening for hearing disability: a study of potential screening tests and models.
    Davis A; Smith P; Ferguson M; Stephens D; Gianopoulos I
    Health Technol Assess; 2007 Oct; 11(42):1-294. PubMed ID: 17927921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incremental yield of ECG screening repeated annually over 4 years in an adult Japanese population without prior atrial fibrillation: a retrospective cohort study.
    Nagata Y; Yamagami T; Nutbeam D; Freedman B; Lowres N
    BMJ Open; 2020 Jul; 10(7):e035650. PubMed ID: 32690510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-Effectiveness of a National Opportunistic Screening Program for Atrial Fibrillation in Ireland.
    Moran PS; Teljeur C; Harrington P; Smith SM; Smyth B; Harbison J; Normand C; Ryan M
    Value Health; 2016 Dec; 19(8):985-995. PubMed ID: 27987649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 94.